PMVP Pmv Pharmaceuticals, Inc.
Fundamentals / CIK 0001699382 / USDPmv Pharmaceuticals, Inc. reported $111.4M in total assets and a net loss of $88.53M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PMVP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$77.20M Operating profit
-
Net Income FY 2025-$88.53M GAAP bottom line
-
Diluted EPS FY 2025-$1.34 Split-adjusted
-
Free Cash Flow FY 2025-$69.64M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$102.6M Total debt: $138K
Annual revenue and net income
8 fiscal years (2018 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $69.88M | $58.53M | $55.88M | $51.99M | $36.49M | $23.93M | $20.76M | $13.85M |
| Total Operating Expenses | $86.21M | $85.45M | $80.13M | $77.04M | $58.29M | $34.94M | $26.64M | $18.89M |
| Operating Income | -$86.21M | -$85.45M | -$80.13M | -$77.04M | -$58.29M | -$34.94M | -$26.64M | -$18.89M |
| EBITDA | -$86.07M | -$84.30M | -$78.88M | -$76.72M | -$57.99M | -$34.62M | -$26.25M | -$18.55M |
| Income Before Tax | -$79.91M | -$74.81M | -$68.96M | -$73.33M | -$57.82M | -$34.43M | -$25.34M | -$17.54M |
| Income Tax Expense | -$2.17M | -$16.10M | $2.0K | -$9.0K | $23K | $6.0K | $8.0K | $3.0K |
| Net Income | -$77.74M | -$58.71M | -$68.96M | -$73.32M | -$57.85M | -$34.44M | -$25.35M | -$17.54M |
| Basic EPS | -$1.48 | -$1.14 | -$1.44 | -$1.61 | -$1.28 | -$2.40 | -$8.35 | -$5.82 |
| Diluted EPS | -$1.48 | -$1.14 | -$1.44 | -$1.61 | -$1.28 | -$2.40 | -$8.35 | -$5.82 |
| Basic Shares Outstanding | 52.5M | 51.6M | 48.0M | 45.6M | 45.1M | 14.4M | 3.0M | 3.0M |
| Diluted Shares Outstanding | 52.5M | 51.6M | 48.0M | 45.6M | 45.1M | 14.4M | 3.0M | 3.0M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $16.06M | $14.68M | $15.33M | $15.83M | $18.21M | $18.40M | $17.44M | $13.77M |
| Total Operating Expenses | $20.06M | $18.88M | $19.02M | $19.24M | $22.52M | $22.88M | $21.56M | $25.17M |
| Operating Income | -$20.06M | -$18.88M | -$19.02M | -$19.24M | -$22.52M | -$22.88M | -$21.56M | -$25.17M |
| EBITDA | -$20.04M | -$18.86M | -$18.98M | -$19.21M | -$22.49M | -$22.85M | -$21.53M | -$25.13M |
| Income Before Tax | -$34.38M | -$18.08M | -$18.04M | -$18.01M | -$21.07M | -$21.20M | -$19.63M | -$23.00M |
| Income Tax Expense | -$7.0K | $3.0K | -- | $26K | -$6.0K | $5.0K | -$2.20M | -- |
| Net Income | -$34.37M | -$18.09M | -$18.04M | -$18.04M | -$21.06M | -$21.21M | -$17.44M | -$23.00M |
| Basic EPS | -$0.52 | -$0.34 | -$0.34 | -- | -$0.40 | -$0.41 | -$0.34 | -- |
| Diluted EPS | -$0.52 | -$0.34 | -$0.34 | -- | -$0.40 | -$0.41 | -$0.34 | -- |
| Basic Shares Outstanding | 66.2M | 53.4M | 53.3M | -- | 53.0M | 52.0M | 52.0M | -- |
| Diluted Shares Outstanding | 66.2M | 53.4M | 53.3M | -- | 53.0M | 52.0M | 52.0M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $37.98M | $40.88M | $37.71M | $108.3M | $172.5M | $361.4M | $73.28M |
| Short-Term Investments | $74.96M | $128.6M | $165.4M | $132.8M | $124.7M | -- | $28.21M |
| Cash & Short-Term Investments | $112.9M | $183.3M | $228.6M | $243.5M | $314.1M | $361.4M | $101.5M |
| Total Current Assets | $115.2M | $175.7M | $207.4M | $247.0M | $301.3M | $364.8M | $102.1M |
| Property, Plant & Equipment, Net | $237K | $409K | $10.67M | $10.96M | $3.09M | $569K | $739K |
| Long-Term Investments | $0 | $13.84M | $25.50M | $2.50M | $16.91M | -- | -- |
| Other Non-Current Assets | $297K | $235K | $190K | $313K | $221K | $201K | $201K |
| Total Non-Current Assets | $1.33M | $15.63M | $44.74M | $23.30M | $30.28M | $770K | $940K |
| Total Assets | $116.6M | $191.3M | $252.2M | $270.3M | $331.6M | $365.5M | $103.0M |
| Accounts Payable | $3.15M | $6.58M | $3.24M | $3.00M | $3.19M | $1.61M | $2.84M |
| Total Current Liabilities | $11.41M | $14.37M | $14.03M | $10.83M | $12.22M | $6.41M | $4.52M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | $51K |
| Total Non-Current Liabilities | $435K | $838K | $12.43M | $13.45M | $10.79M | $0 | $51K |
| Total Liabilities | $11.85M | $15.21M | $26.46M | $24.28M | $23.01M | $6.41M | $4.57M |
| Total Debt (incl. Leases) | $838K | $1.19M | $13.29M | $13.98M | $11.19M | -- | -- |
| Retained Earnings | -$446.5M | -$368.7M | -$310.0M | -$241.0M | -$167.7M | -$109.9M | -$75.44M |
| Accumulated Other Comp. Income | $84K | $139K | $224K | -$445K | -$78K | -- | -$3.0K |
| Total Stockholders' Equity | $104.7M | $176.1M | $225.7M | $246.0M | $308.6M | $359.1M | -$70.47M |
| Total Equity | $104.7M | $176.1M | $225.7M | $246.0M | $308.6M | $359.1M | -$70.47M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $19.99M | $12.47M | $39.13M | $37.98M | $36.34M | $44.13M | $51.34M | $40.88M |
| Short-Term Investments | $82.57M | $66.96M | $54.42M | $74.96M | $92.91M | $98.15M | $109.0M | $128.6M |
| Cash & Short-Term Investments | $108.5M | $79.43M | $93.55M | $112.9M | $129.2M | $148.3M | $165.8M | $183.3M |
| Total Current Assets | $104.9M | $81.41M | $95.78M | $115.2M | $132.4M | $145.3M | $163.5M | $175.7M |
| Property, Plant & Equipment, Net | $131K | $154K | $203K | $237K | $255K | $287K | $376K | $409K |
| Long-Term Investments | $5.96M | $0 | $0 | $0 | $0 | $6.03M | $5.43M | $13.84M |
| Other Non-Current Assets | $291K | $296K | $296K | $297K | $249K | $248K | $237K | $235K |
| Total Non-Current Assets | $6.51M | $659K | $782K | $1.33M | $1.40M | $7.54M | $7.11M | $15.63M |
| Total Assets | $111.4M | $82.07M | $96.56M | $116.6M | $133.8M | $152.9M | $170.6M | $191.3M |
| Accounts Payable | $1.64M | $2.02M | $1.63M | $3.15M | $3.40M | $2.60M | $3.59M | $6.58M |
| Total Current Liabilities | $10.69M | $10.57M | $8.60M | $11.41M | $12.30M | $11.61M | $9.76M | $14.37M |
| Total Non-Current Liabilities | $43.61M | $0 | $0 | $435K | $541K | $643K | $742K | $838K |
| Total Liabilities | $54.30M | $10.57M | $8.60M | $11.85M | $12.85M | $12.25M | $10.50M | $15.21M |
| Total Debt (incl. Leases) | $138K | $217K | $293K | $838K | $931K | $1.02M | $1.11M | $1.19M |
| Retained Earnings | -$517.0M | -$482.6M | -$464.5M | -$446.5M | -$428.4M | -$407.4M | -$386.1M | -$368.7M |
| Accumulated Other Comp. Income | -$156K | -$82K | -$15K | $84K | $91K | $21K | $84K | $139K |
| Total Stockholders' Equity | $57.11M | $71.50M | $87.97M | $104.7M | $121.0M | $140.6M | $160.1M | $176.1M |
| Total Equity | $57.11M | $71.50M | $87.97M | $104.7M | $121.0M | $140.6M | $160.1M | $176.1M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$77.74M | -$58.71M | -$68.96M | -$73.32M | -$57.85M | -$34.44M | -$25.35M | -$17.54M |
| Depreciation & Amortization | $133K | $1.14M | $1.26M | $315K | $307K | $318K | $388K | $338K |
| Stock-Based Compensation | $5.92M | $8.87M | $12.38M | $10.20M | $5.34M | $1.93M | $908K | $1.08M |
| Change in Payables | -$3.42M | $3.34M | $235K | -$389K | $191K | -$1.23M | $1.80M | $267K |
| Operating Cash Flow | -$73.58M | -$51.28M | -$55.66M | -$63.76M | -$46.57M | -$32.74M | -$22.07M | -$15.18M |
| Capital Expenditure | -$29K | -$655K | -$962K | -$7.98M | -$1.35M | -$148K | -$109K | -$452K |
| Free Cash Flow | -$73.61M | -$51.94M | -$56.62M | -$71.74M | -$47.92M | -$32.89M | -$22.17M | -$15.63M |
| Purchases of Investments | -$88.20M | -$148.3M | -$220.5M | -$229.2M | -$256.8M | -$14.51M | -$43.45M | -$48.68M |
| Investing Cash Flow | $70.17M | $53.35M | -$50.55M | -$1.37M | -$143.6M | $27.91M | $3.23M | $21.69M |
| Common Stock Issued | -- | -- | $35.12M | -- | -- | $223.2M | -- | -- |
| Financing Cash Flow | $505K | $313K | $35.58M | $958K | $2.02M | $293.0M | $61.80M | -- |
| Net Change in Cash | -$2.89M | $2.35M | -$70.59M | -$64.17M | -$188.1M | $288.1M | $42.97M | $6.51M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$34.37M | -$18.09M | -$18.04M | -$18.04M | -$21.06M | -$21.21M | -$17.44M | -$23.00M |
| Depreciation & Amortization | $23K | $24K | $34K | $33K | $32K | $32K | $37K | $39K |
| Stock-Based Compensation | $1.60M | $1.54M | $1.39M | $1.36M | $1.38M | $1.67M | $1.51M | $1.27M |
| Change in Payables | -$382K | $389K | -$1.52M | -$244K | $801K | -$995K | -$2.99M | $4.52M |
| Operating Cash Flow | -$18.18M | -$14.58M | -$19.68M | -$17.19M | -$19.82M | -$18.30M | -$18.27M | -$16.66M |
| Capital Expenditure | $0 | $0 | $0 | -$15K | $1.0K | -$11K | -$4.0K | -$56K |
| Free Cash Flow | -$18.18M | -$14.58M | -$19.68M | -$17.20M | -$19.82M | -$18.31M | -$18.27M | -$16.72M |
| Purchases of Investments | -$41.16M | -$26.73M | -$10.68M | -$21.04M | -$20.47M | -$30.96M | -$15.73M | -$37.51M |
| Investing Cash Flow | -$21.20M | -$12.23M | $20.82M | $18.44M | $12.03M | $10.99M | $28.71M | $7.74M |
| Financing Cash Flow | $46.91M | $143K | $0 | $392K | $0 | $103K | $10K | $172K |
| Net Change in Cash | $7.53M | -$26.66M | $1.15M | $1.65M | -$7.79M | -$7.21M | $10.46M | -$8.76M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -74.2% | -33.3% | -30.6% | -29.8% | -18.7% | -9.6% | -- | -- |
| Return on Assets (ROA) | -66.7% | -30.7% | -27.3% | -27.1% | -17.4% | -9.4% | -24.6% | -- |
| Current Ratio | 10.09x | 12.22x | 14.78x | 22.80x | 24.66x | 56.90x | 22.57x | -- |
| Quick Ratio | 9.89x | 12.76x | 16.29x | 22.48x | 25.70x | 56.38x | 22.44x | -- |
| Debt to Equity | 0.01x | 0.01x | 0.06x | 0.06x | 0.04x | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -155.0% | -105.2% | -89.1% | -74.2% | -68.4% | -57.5% | -38.0% | -33.3% |
| Return on Assets (ROA) | -79.5% | -91.7% | -81.1% | -66.7% | -61.8% | -52.9% | -35.7% | -30.7% |
| Current Ratio | 9.81x | 7.70x | 11.14x | 10.09x | 10.76x | 12.52x | 16.75x | 12.22x |
| Quick Ratio | 10.15x | 7.52x | 10.88x | 9.89x | 10.50x | 12.78x | 16.99x | 12.76x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |